Current medical and surgical management of Raynaud's syndrome-Reference-Cited by-同舟云学术

Current medical and surgical management of Raynaud's syndrome

Published:2013-06 Issue:6 Volume:57 Page:1710-1716
ISSN:0741-5214
Container-title:Journal of Vascular Surgery
language:en
Short-container-title:Journal of Vascular Surgery

Author:

Landry Gregory J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Surgery

Reference44 articles.

1. U.S. Preventive Services Task Force. Guide to clinical preventive services: report of the U.S. Preventive Services Task Force,1989

2. Inefficacy of diltiazem in the treatment of Raynaud's phenomenon with associated connective tissue disease: a double blind placebo controlled study;Da Costa;J Rheumatol,1987

3. Comparison of sustained-release nifedipine and temperature biofeedback for treatment of primary Raynaud phenomenon: results from a randomized clinical trial with 1-year follow-up;Arch Intern Med,2000

4. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis;Thompson;Rheumatology,2005

5. Amlodipine in the treatment of Raynaud's phenomenon;La Civita;Br J Rheumatol,1993

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and functional analysis of Raynaud’s syndrome implicates loci in vasculature and immunity;Cell Genomics;2024-09

2. Estrogen Receptor and the Gender Bias in Raynaud’s Phenomenon;Current Medicinal Chemistry;2024-01

3. GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells;Journal of Cardiovascular Pharmacology;2023-12

4. Dynamic blood flow imaging with 99mTc-hydroxymethylene diphosphonate as a therapeutic response marker in patients with Raynaud’s phenomenon;Scientific Reports;2023-11-13

5. The α_2A-adrenergic receptor (ADRA2A) modulates susceptibility to Raynaud’s syndrome;2023-10-05